Head-To-Head Comparison: Glucose Health (OTCMKTS:GLUC) & EssilorLuxottica (OTCMKTS:ESLOY)

EssilorLuxottica (OTCMKTS:ESLOYGet Free Report) and Glucose Health (OTCMKTS:GLUCGet Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for EssilorLuxottica and Glucose Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EssilorLuxottica 0 1 5 2 3.13
Glucose Health 0 0 0 0 0.00

Profitability

This table compares EssilorLuxottica and Glucose Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
EssilorLuxottica N/A N/A N/A
Glucose Health -108.70% N/A N/A

Risk and Volatility

EssilorLuxottica has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Glucose Health has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.

Valuation and Earnings

This table compares EssilorLuxottica and Glucose Health”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
EssilorLuxottica $32.23 billion 3.23 $2.62 billion N/A N/A
Glucose Health $380,000.00 20.03 -$320,000.00 ($0.03) -12.41

EssilorLuxottica has higher revenue and earnings than Glucose Health.

Insider & Institutional Ownership

0.0% of EssilorLuxottica shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

EssilorLuxottica beats Glucose Health on 7 of the 9 factors compared between the two stocks.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

About Glucose Health

(Get Free Report)

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.